<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To present the first report of a thromboembolic complication in early pregnancy after ovarian hyperstimulation for IVF in a patient with AT III deficiency who was treated successfully and subsequently delivered a healthy male infant at 32 weeks of gestation </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Case report </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: Hospital-based clinic for reproductive medicine </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENT: A 28-year-old woman who consulted our IVF clinic with a 3.5-year history of primary <z:hpo ids='HP_0000789'>infertility</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>INTERVENTIONS: Intravenous <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The patient responded adequately to <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy and was discharged home on SC <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>A primary cesarean section was performed at 32 weeks of gestation because of poor fetal growth and transverse lie </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: We stress the importance of obtaining a thorough personal and family history before initiation of ovarian hyperstimulation </plain></SENT>
<SENT sid="8" pm="."><plain>Measuring activity of AT III, protein C, and protein S in patients with a suspicious history of thromboembolic episodes occurring at an early age may lead to the implementation of appropriate prophylactic measures, preventing potentially life-threatening complications </plain></SENT>
</text></document>